# Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome

> **NCT04357392** · EARLY_PHASE1 · UNKNOWN · sponsor: **chenfengling** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT04357392
- **Lead sponsor:** chenfengling
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-20
- **Primary completion:** 2022-05-20
- **Final completion:** 2023-05-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04357392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04357392, "Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04357392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*